Legend Biotech Corporation (LEGN)
USD 33.17
(-2.33%)
USD 33.17
(-2.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.84 Billion USD | 38.89% |
| 2022 | 1.33 Billion USD | 19.01% |
| 2021 | 1.11 Billion USD | 55.11% |
| 2020 | 721 Million USD | 150.6% |
| 2019 | 287.71 Million USD | -32.94% |
| 2018 | 429.04 Million USD | 79.75% |
| 2017 | 238.69 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.77 Billion USD | -3.98% |
| 2024 Q2 | 1.79 Billion USD | 1.3% |
| 2023 Q1 | 1.2 Billion USD | -9.14% |
| 2023 Q4 | 1.84 Billion USD | 0.5% |
| 2023 Q2 | 1.93 Billion USD | 59.64% |
| 2023 FY | 1.84 Billion USD | 38.89% |
| 2023 Q3 | 1.83 Billion USD | -4.73% |
| 2022 Q1 | 1.04 Billion USD | -6.96% |
| 2022 Q4 | 1.33 Billion USD | 0.0% |
| 2022 Q3 | 1.33 Billion USD | 30.14% |
| 2022 FY | 1.33 Billion USD | 19.01% |
| 2022 Q2 | 1.02 Billion USD | -1.71% |
| 2021 Q1 | 615.25 Million USD | -14.67% |
| 2021 FY | 1.11 Billion USD | 55.11% |
| 2021 Q4 | 1.11 Billion USD | 37.43% |
| 2021 Q3 | 813.76 Million USD | -7.01% |
| 2021 Q2 | 875.12 Million USD | 42.24% |
| 2020 Q4 | 721 Million USD | 1.75% |
| 2020 FY | 721 Million USD | 150.6% |
| 2020 Q2 | 772.86 Million USD | 111.78% |
| 2020 Q1 | 364.93 Million USD | 26.84% |
| 2020 Q3 | 708.63 Million USD | -8.31% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 287.71 Million USD | -32.94% |
| 2019 Q4 | 287.71 Million USD | 0.0% |
| 2018 FY | 429.04 Million USD | 79.75% |
| 2017 FY | 238.69 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Absci Corporation | 234.48 Million USD | -688.387% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -179.612% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 51.732% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -292592.23% |
| Apollomics, Inc. | 55.38 Million USD | -3237.623% |
| 180 Life Sciences Corp. | 5.25 Million USD | -35048.159% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -1820.593% |
| Bicycle Therapeutics plc | 595.34 Million USD | -210.511% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -761.798% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -2408.221% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -2356.036% |
| Chimerix, Inc. | 212.77 Million USD | -768.813% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 17.087% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -1317.797% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -420.465% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1003.476% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1003.476% |
| Gritstone bio, Inc. | 177.76 Million USD | -939.894% |
| Allakos Inc. | 243.61 Million USD | -658.84% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -1323.167% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -1368.969% |
| Cytokinetics, Incorporated | 824.31 Million USD | -124.26% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -2025.84% |
| Innoviva, Inc. | 1.24 Billion USD | -48.661% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -19317.595% |
| NLS Pharmaceutics AG | 1.84 Million USD | -100006.572% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -966.532% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -27966.538% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -588.451% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -1212.392% |
| ImmuCell Corporation | 43.8 Million USD | -4119.788% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -184.701% |
| Incyte Corporation | 6.78 Billion USD | 72.743% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -968.904% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -59842.198% |
| Mustang Bio, Inc. | 17.74 Million USD | -10319.395% |
| MiMedx Group, Inc. | 239.04 Million USD | -673.324% |
| MEI Pharma, Inc. | 41.37 Million USD | -4367.937% |
| MacroGenics, Inc. | 306.82 Million USD | -502.506% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -25067.719% |
| Mereo BioPharma Group plc | 66.49 Million USD | -2679.905% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -10693.29% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -981.64% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -24.28% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -3148.839% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -8014.696% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -58105.573% |
| NextCure, Inc. | 129.41 Million USD | -1328.402% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -1841.571% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -3326.65% |
| Onconetix, Inc. | 88.82 Million USD | -1981.264% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -4933.105% |
| Opthea Limited | 188.79 Million USD | -879.182% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -1183.518% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -163181.748% |
| PDS Biotechnology Corporation | 59.39 Million USD | -3012.656% |
| Precigen, Inc. | 151.04 Million USD | -1123.896% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -4679.237% |
| Prime Medicine, Inc. | 193.85 Million USD | -853.624% |
| PureTech Health plc | 693.97 Million USD | -166.381% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -226.413% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 94.412% |
| Replimune Group, Inc. | 487.72 Million USD | -279.029% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -15036.888% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -1476.975% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -35658.528% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 11.49% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -9668.763% |
| Sesen Bio, Inc. | 189.17 Million USD | -877.2% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -1018.2% |
| Solid Biosciences Inc. | 164.93 Million USD | -1020.783% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -201.627% |
| SciSparc Ltd. | 11.18 Million USD | -16432.007% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -292.706% |
| TG Therapeutics, Inc. | 329.58 Million USD | -460.887% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -1096.844% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -22761.848% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -134.324% |
| UroGen Pharma Ltd. | 178.31 Million USD | -936.733% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -2165.535% |
| XOMA Corporation | 234.3 Million USD | -688.989% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -228.918% |
| AbCellera Biologics Inc. | 1.48 Billion USD | -24.227% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -3546.387% |
| Cassava Sciences, Inc. | 151.66 Million USD | -1118.893% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -6438.566% |
| Precision BioSciences, Inc. | 159.78 Million USD | -1056.964% |
| Dyadic International, Inc. | 8.21 Million USD | -22391.251% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -10588.69% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -5724.225% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -1792.418% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -984.133% |
| IGM Biosciences, Inc. | 423.41 Million USD | -336.599% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -1155.354% |
| Acelyrin, Inc. | 742.69 Million USD | -148.907% |
| Abeona Therapeutics Inc. | 64 Million USD | -2788.361% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -121.905% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -12643.186% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -330.508% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -999.224% |
| Senti Biosciences, Inc. | 119.48 Million USD | -1447.16% |
| Mesoblast Limited | 669.15 Million USD | -176.261% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -221.073% |
| ChromaDex Corporation | 54.96 Million USD | -3263.309% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -31380.362% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -664.827% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -23069.492% |
| Seer, Inc. | 436.26 Million USD | -323.731% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -442.435% |
| Novavax, Inc. | 1.85 Billion USD | 0.363% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -19099.655% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -265.181% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -34273.54% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -146.472% |
| Celcuity Inc. | 191.21 Million USD | -866.748% |
| ContextLogic Inc. | 423 Million USD | -337.023% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -346.694% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -1045.806% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 83.775% |
| Amarin Corporation plc | 831.68 Million USD | -122.273% |
| AnaptysBio, Inc. | 452.38 Million USD | -308.633% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -7341.466% |
| Aptorum Group Limited | 20.64 Million USD | -8856.399% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -506.002% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -141.474% |
| Ardelyx, Inc. | 297.57 Million USD | -521.216% |
| Celularity Inc. | 143.88 Million USD | -1184.747% |
| Omeros Corporation | 378.26 Million USD | -388.702% |
| Humacyte, Inc. | 128.22 Million USD | -1341.714% |
| Immunocore Holdings plc | 597 Million USD | -209.649% |
| IO Biotech, Inc. | 150.71 Million USD | -1126.535% |
| GT Biopharma, Inc. | 14.1 Million USD | -13002.339% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -628.803% |
| Summit Therapeutics Inc. | 202.94 Million USD | -810.874% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -22272.129% |
| Pulmatrix, Inc. | 33.95 Million USD | -5343.81% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -42.094% |
| Evogene Ltd. | 51.1 Million USD | -3517.559% |
| CorMedix Inc. | 82.05 Million USD | -2152.754% |
| BioLineRx Ltd. | 63.92 Million USD | -2791.84% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -1394.997% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -1811.319% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | 2.867% |
| scPharmaceuticals Inc. | 94.47 Million USD | -1856.635% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -617.366% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -197.435% |
| NLS Pharmaceutics AG | 1.84 Million USD | -100006.572% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -9668.763% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -218.577% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -1573.419% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -3279.912% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -709.579% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -1620.661% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -5623.07% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -10144.463% |
| Daré Bioscience, Inc. | 21.28 Million USD | -8586.168% |
| bluebird bio, Inc. | 619.16 Million USD | -198.567% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 72.98% |
| DBV Technologies S.A. | 182.98 Million USD | -910.246% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -194.105% |
| Galecto, Inc. | 38.22 Million USD | -4735.873% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -2385.558% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -1678.432% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -500.406% |
| GlycoMimetics, Inc. | 45.31 Million USD | -3979.331% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -441.534% |
| ADMA Biologics, Inc. | 329.18 Million USD | -461.577% |
| Clene Inc. | 52.34 Million USD | -3431.856% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -182.792% |
| Aptose Biosciences Inc. | 12.92 Million USD | -14205.302% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -8259.344% |
| Soligenix, Inc. | 9.79 Million USD | -18768.506% |
| Century Therapeutics, Inc. | 360.69 Million USD | -412.519% |
| Kura Oncology, Inc. | 448.93 Million USD | -311.777% |
| Surrozen, Inc. | 46.08 Million USD | -3911.738% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -579.264% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -1566.745% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -801.097% |
| Autolus Therapeutics plc | 375.38 Million USD | -392.462% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -634.636% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -3662.536% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -319.216% |
| GRI Bio, Inc. | 2.95 Million USD | -62437.517% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -17331.114% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -385.956% |
| INmune Bio, Inc. | 57 Million USD | -3143.117% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -730.813% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2102.265% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -6978.221% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -15720.864% |
| Jaguar Health, Inc. | 50.76 Million USD | -3541.646% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -26756.845% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -2357.407% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -5334.208% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -1016.957% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -193.615% |
| Verastem, Inc. | 149.71 Million USD | -1134.727% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -260.948% |
| Histogen Inc. | 19.07 Million USD | -9592.282% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -8061.566% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -146.825% |
| Surrozen, Inc. | 46.08 Million USD | -3911.738% |
| Organovo Holdings, Inc. | 6.34 Million USD | -29016.538% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -42804.898% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -21599.199% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -409.302% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -10116.472% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -14557.866% |
| Kronos Bio, Inc. | 213.27 Million USD | -766.756% |
| Turnstone Biologics Corp. | 112.81 Million USD | -1538.62% |
| Synaptogenix, Inc. | 31.11 Million USD | -5841.469% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -15072.431% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -293.998% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -237.299% |
| Exelixis, Inc. | 2.94 Billion USD | 37.173% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -407.109% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -134.378% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -1838.152% |
| ESSA Pharma Inc. | 149.12 Million USD | -1139.661% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -10249.239% |
| Avid Bioservices, Inc. | 336.55 Million USD | -449.271% |
| Insmed Incorporated | 1.32 Billion USD | -39.01% |
| MediWound Ltd. | 66.45 Million USD | -2681.578% |
| OmniAb, Inc. | 401.98 Million USD | -359.87% |
| Alector, Inc. | 621.82 Million USD | -197.287% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -415.507% |
| Zai Lab Limited | 1.03 Billion USD | -78.386% |
| AlloVir, Inc. | 190.79 Million USD | -868.893% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -286.371% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -625.838% |
| Aura Biosciences, Inc. | 255.07 Million USD | -624.732% |
| Immunic, Inc. | 54.29 Million USD | -3304.499% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -594.381% |
| Veracyte, Inc. | 1.13 Billion USD | -62.469% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -15535.99% |
| FibroGen, Inc. | 423.52 Million USD | -336.478% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -52521.947% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -291.732% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -38928.144% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -33947.638% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -20894.991% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -257.251% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 57.573% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -685.292% |
| XBiotech Inc. | 227.24 Million USD | -713.494% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -1838.152% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -399.59% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -28770.982% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -1196.36% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -546.557% |
| Agenus Inc. | 313.91 Million USD | -488.892% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -1345.705% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -383.93% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -23.983% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -406.688% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -257.592% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -9833.775% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -391.062% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -17152.228% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -8245.438% |
| Lantern Pharma Inc. | 43.64 Million USD | -4135.303% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -1368.385% |
| Ainos, Inc. | 31.84 Million USD | -5705.604% |
| Pluri Inc. | 39.52 Million USD | -4576.826% |
| Prothena Corporation plc | 696.38 Million USD | -165.459% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -554.106% |
| Rallybio Corporation | 115.62 Million USD | -1498.866% |
| Kodiak Sciences Inc. | 479.37 Million USD | -285.631% |
| Cue Biopharma, Inc. | 61.53 Million USD | -2904.403% |
| MeiraGTx Holdings plc | 458.16 Million USD | -303.478% |
| Annexon, Inc. | 297.67 Million USD | -521.018% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -1244.746% |
| Moderna, Inc. | 18.42 Billion USD | 89.967% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -5813.846% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -2597.518% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -76.184% |
| Immix Biopharma, Inc. | 19.92 Million USD | -9177.762% |
| CalciMedica, Inc. | 12.18 Million USD | -15071.186% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -508.586% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -494.341% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -572.346% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -227.014% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -6709.876% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -1319.942% |
| Nutriband Inc. | 7.51 Million USD | -24491.873% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -2241.375% |
| Vor Biopharma Inc. | 209.82 Million USD | -781.012% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 74.405% |
| Alkermes plc | 2.13 Billion USD | 13.464% |
| ProKidney Corp. | 420.55 Million USD | -339.567% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -3271.344% |
| Arcellx, Inc. | 825.13 Million USD | -124.038% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -238.338% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -359.205% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -6455.351% |
| Atai Life Sciences N.V. | 293.47 Million USD | -529.897% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -1033.216% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -1350.822% |
| MediciNova, Inc. | 66.26 Million USD | -2689.512% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -2001.934% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -41326.665% |
| GeoVax Labs, Inc. | 9.28 Million USD | -19813.448% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -214.263% |
| Biomea Fusion, Inc. | 199.92 Million USD | -824.642% |
| RenovoRx, Inc. | 1.46 Million USD | -125998.84% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -281.081% |
| Geron Corporation | 394.07 Million USD | -369.1% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -25171.483% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -443.883% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -1019.813% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -251.232% |
| Royalty Pharma plc | 16.38 Billion USD | 88.716% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -565.702% |
| Imunon, Inc. | 21.91 Million USD | -8334.178% |
| BioAtla, Inc. | 119.65 Million USD | -1444.91% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -187.57% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -1826.939% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -717.751% |
| Structure Therapeutics Inc. | 482.01 Million USD | -283.515% |
| 89bio, Inc. | 596.26 Million USD | -210.029% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -735.586% |
| aTyr Pharma, Inc. | 122.06 Million USD | -1414.422% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -1101.152% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -276.941% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -12095.955% |
| Akari Therapeutics, Plc | 4.35 Million USD | -42347.968% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -10750.343% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -6.654% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -705.743% |
| Liquidia Corporation | 120.43 Million USD | -1434.994% |
| Entera Bio Ltd. | 11.76 Million USD | -15612.784% |
| GH Research PLC | 226.3 Million USD | -716.884% |
| Vericel Corporation | 353.65 Million USD | -422.712% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -1180.191% |
| Xencor, Inc. | 952.69 Million USD | -94.041% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -23649.53% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -6978.221% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -22804.084% |
| Vaxcyte, Inc. | 1.4 Billion USD | -31.301% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -91.606% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -185.086% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -59842.198% |
| Portage Biotech Inc. | 7.77 Million USD | -23664.096% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -41326.665% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -567.5% |
| OncoCyte Corporation | 74.89 Million USD | -2368.366% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -90819.012% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -31846.139% |
| Purple Biotech Ltd. | 44.3 Million USD | -4072.744% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -3482.367% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -3981.986% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -455.563% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -5317.01% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -4737.138% |
| United Therapeutics Corporation | 7.16 Billion USD | 74.207% |
| HilleVax, Inc. | 344.43 Million USD | -436.709% |
| Silo Pharma, Inc. | 7.74 Million USD | -23764.903% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -38624.316% |
| Pharming Group N.V. | 462.85 Million USD | -299.394% |
| Tharimmune, Inc. | 10.94 Million USD | -16787.837% |
| Genprex, Inc. | 10.67 Million USD | -17224.334% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -360.536% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -272.557% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -964.095% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -76099.876% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -44279.671% |
| OKYO Pharma Limited | 1.54 Million USD | -119841.1% |
| Savara Inc. | 177.56 Million USD | -941.094% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -5604.527% |
| Curis, Inc. | 77.28 Million USD | -2292.03% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -2790.764% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -9443.178% |
| BeiGene, Ltd. | 5.8 Billion USD | 68.156% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -416.442% |
| Erasca, Inc. | 395.29 Million USD | -367.651% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -42658.529% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -42658.529% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -10047.714% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -15855.541% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -1237.004% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -297.015% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -489.786% |
| Adicet Bio, Inc. | 207.29 Million USD | -791.777% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -137.647% |
| Aditxt, Inc. | 44.57 Million USD | -4046.878% |
| Adagene Inc. | 115.72 Million USD | -1497.362% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -41402.707% |
| Quantum-Si incorporated | 298.25 Million USD | -519.819% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -23879.498% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -426.248% |
| Compugen Ltd. | 121.33 Million USD | -1423.57% |
| Generation Bio Co. | 374.75 Million USD | -393.281% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -625.895% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -1065.822% |
| Invivyd, Inc. | 229.18 Million USD | -706.615% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -119.035% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -15090.757% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -913.547% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -8951.16% |
| 2seventy bio, Inc. | 565.42 Million USD | -226.941% |
| Instil Bio, Inc. | 325.63 Million USD | -467.702% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -3047.408% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -35519.233% |
| GeoVax Labs, Inc. | 9.28 Million USD | -19813.448% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -1684.18% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -1794.998% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -662.146% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | 5.688% |
| Evaxion Biotech A/S | 12.88 Million USD | -14242.956% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -633.4% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -145.601% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -718.486% |
| Cingulate Inc. | 3.49 Million USD | -52846.954% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -11016.778% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -2714.141% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -1368.409% |
| Clearmind Medicine Inc. | 4.32 Million USD | -42648.444% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -1056.942% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -21494.361% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -401.671% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -188.598% |
| ImmunityBio, Inc. | 504.45 Million USD | -266.459% |
| Korro Bio, Inc. | 221.66 Million USD | -733.973% |
| Kineta, Inc. | 10.28 Million USD | -17880.829% |
| BioVie Inc. | 25.2 Million USD | -7233.322% |
| Codexis, Inc. | 136.56 Million USD | -1253.687% |
| Celularity Inc. | 143.88 Million USD | -1184.747% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -1449.728% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -190.958% |
| Virax Biolabs Group Limited | 5.48 Million USD | -33609.326% |
| Cibus, Inc. | 544.41 Million USD | -239.561% |
| IN8bio, Inc. | 33.7 Million USD | -5384.022% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -968.498% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -8705.835% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 38.175% |
| Eyenovia, Inc. | 28.77 Million USD | -6323.382% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -701.902% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -25489.826% |
| Elevation Oncology, Inc. | 89.09 Million USD | -1974.967% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -2934.187% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -2164.425% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -299.894% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -5911.737% |
| Moolec Science SA | 24.05 Million USD | -7586.112% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -496.085% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -1717.529% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -210.707% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -1078.396% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -26328.276% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -15270.088% |
| Humacyte, Inc. | 128.22 Million USD | -1341.714% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -633.133% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -99824.811% |
| Genelux Corporation | 27.89 Million USD | -6527.502% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -1967.726% |
| Notable Labs, Ltd. | 19.54 Million USD | -9360.156% |
| Immunovant, Inc. | 666.71 Million USD | -177.272% |
| Quantum-Si incorporated | 298.25 Million USD | -519.819% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -3313.237% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -953.062% |
| Acasti Pharma Inc. | 73.3 Million USD | -2421.977% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -40508.411% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -923.078% |
| PepGen Inc. | 143.05 Million USD | -1192.264% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -9535.7% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -31380.362% |
| Immuneering Corporation | 102.58 Million USD | -1702.035% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -42804.898% |
| Belite Bio, Inc | 94.64 Million USD | -1853.265% |
| XOMA Corporation | 234.3 Million USD | -688.989% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -692.755% |
| Bionomics Limited | 27.64 Million USD | -6585.966% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1621.43% |
| uniQure N.V. | 831.68 Million USD | -122.272% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -41402.707% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -574.958% |
| Forte Biosciences, Inc. | 38.98 Million USD | -4642.455% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -45285.644% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -4919.166% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -25489.826% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -52521.947% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -15538.347% |
| Altimmune, Inc. | 210.64 Million USD | -777.615% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -880.923% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1621.43% |
| Peak Bio, Inc. | 2.59 Million USD | -71098.518% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -972.733% |
| Benitec Biopharma Inc. | 52.21 Million USD | -3440.718% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -440.752% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -5216.219% |
| Zura Bio Limited | 100.84 Million USD | -1733.155% |
| PolyPid Ltd. | 15.37 Million USD | -11925.82% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -5216.219% |
| argenx SE | 4.54 Billion USD | 59.304% |
| Immunome, Inc. | 148.54 Million USD | -1144.519% |
| Verona Pharma plc | 308.12 Million USD | -499.956% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -2025.84% |
| Shattuck Labs, Inc. | 159.56 Million USD | -1058.538% |
| CervoMed Inc. | 9.97 Million USD | -18437.028% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -16132.956% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -930.411% |
| Moolec Science SA | 24.05 Million USD | -7586.112% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -30118.472% |
| Design Therapeutics, Inc. | 289.64 Million USD | -538.237% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -2438.426% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -34019.767% |
| Achilles Therapeutics plc | 161.45 Million USD | -1044.961% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -21494.361% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -827.546% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -2325.614% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -3091.88% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -251.086% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -779.055% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -26.642% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -185.888% |
| AEON Biopharma, Inc. | 6.84 Million USD | -26906.706% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -1295.988% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -579.968% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -13381.815% |
| NeurAxis, Inc. | 509.49 Thousand USD | -362729.491% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -136.895% |
| Lumos Pharma, Inc. | 40.63 Million USD | -4448.966% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -2524.829% |
| Palisade Bio, Inc. | 14.05 Million USD | -13055.487% |
| Nutriband Inc. | 7.51 Million USD | -24491.873% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -592.378% |
| Neurogene Inc. | 222.57 Million USD | -730.563% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -29706.659% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -308.049% |
| Athira Pharma, Inc. | 160.24 Million USD | -1053.614% |
| HCW Biologics Inc. | 28.51 Million USD | -6383.24% |
| XOMA Corporation | 234.3 Million USD | -688.989% |
| Nektar Therapeutics | 398.03 Million USD | -364.436% |
| Arvinas, Inc. | 1.3 Billion USD | -41.699% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -10750.343% |
| Merus N.V. | 458.49 Million USD | -303.192% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -804.558% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -925.842% |
| Rezolute, Inc. | 132.73 Million USD | -1292.686% |
| Clene Inc. | 52.34 Million USD | -3431.856% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -12286.921% |
| BeyondSpring Inc. | 24.8 Million USD | -7351.665% |
| Synlogic, Inc. | 75.55 Million USD | -2346.868% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -15484.294% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -19641.66% |
| Peak Bio, Inc. | 2.59 Million USD | -71098.518% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -957.357% |
| Krystal Biotech, Inc. | 818.35 Million USD | -125.893% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -668.851% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -154.704% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -51577.917% |
| MannKind Corporation | 475.19 Million USD | -289.019% |
| Ikena Oncology, Inc. | 192.09 Million USD | -862.356% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -13722.409% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -1486.258% |
| Gossamer Bio, Inc. | 311.91 Million USD | -492.662% |
| CohBar, Inc. | 16.36 Million USD | -11195.653% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -5157.256% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -25171.483% |
| Mural Oncology plc | 301.74 Million USD | -512.639% |
| Disc Medicine, Inc. | 367.99 Million USD | -402.345% |
| Champions Oncology, Inc. | 26.13 Million USD | -6974.12% |
| REGENXBIO Inc. | 573.97 Million USD | -222.074% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -68162.591% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -1097.394% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -15208.656% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -443.653% |
| Vaxart, Inc. | 91.83 Million USD | -1913.077% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -2985.959% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -1146.307% |
| Cellectis S.A. | 334.27 Million USD | -453.029% |
| Longeveron Inc. | 12.17 Million USD | -15079.906% |
| Repare Therapeutics Inc. | 253.9 Million USD | -628.083% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 43.374% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -820.407% |
| Revolution Medicines, Inc. | 2.08 Billion USD | 11.49% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -113660.554% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -565.659% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -1033.434% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -1232.388% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -7143.198% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 91.867% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -60.203% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -15036.888% |
| Veru Inc. | 50.59 Million USD | -3553.672% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -3958.15% |
| Cingulate Inc. | 3.49 Million USD | -52846.954% |
| Passage Bio, Inc. | 150.54 Million USD | -1127.944% |
| Context Therapeutics Inc. | 16.06 Million USD | -11408.681% |
| Exicure, Inc. | 11.58 Million USD | -15863.808% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -391.589% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -1043.644% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -10480.409% |
| Nuvalent, Inc. | 732.38 Million USD | -152.41% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -12270.177% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -1964.239% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -12926.63% |
| OmniAb, Inc. | 401.98 Million USD | -359.87% |
| Anew Medical, Inc. | 19.45 Million USD | -9401.508% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -6816.75% |
| Lipocine Inc. | 23 Million USD | -7937.056% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -1222.258% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -504.981% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2102.265% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -1420.988% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -23196.9% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -109.527% |
| Ocugen, Inc. | 64.54 Million USD | -2763.974% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -1384.338% |
| Q32 Bio Inc. | 306.11 Million USD | -503.886% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -43830.822% |
| Alumis Inc. Common Stock | 89.61 Million USD | -1962.903% |
| Equillium, Inc. | 50.53 Million USD | -3558.439% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -2358.42% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -4378.922% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -108587.17% |
| Dominari Holdings Inc. | 57.55 Million USD | -3111.733% |
| Edesa Biotech, Inc. | 8.89 Million USD | -20693.23% |
| vTv Therapeutics Inc. | 11.01 Million USD | -16678.081% |
| Bio-Techne Corporation | 2.81 Billion USD | 34.288% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -97.265% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -127.816% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -565.77% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -4332.902% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -176.909% |
| Nkarta, Inc. | 378.88 Million USD | -387.908% |
| BioCardia, Inc. | 2.98 Million USD | -61788.483% |
| Iterum Therapeutics plc | 26.25 Million USD | -6939.906% |